Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers

被引:223
|
作者
Cross, SS
Hamdy, FC
Deloulme, JC
Rehman, I
机构
[1] Univ Sheffield, Sch Med & Biomed Sci, Div Genom Med, Acad Unit Pathol, Sheffield S10 2RX, S Yorkshire, England
[2] Univ Sheffield, Sch Med & Biomed Sci, Div Clin Sci S, Acad Urol Unit, Sheffield S10 2RX, S Yorkshire, England
[3] Commissariat Energie Atom Grenoble, Dept Biol Mol & Struct, INSERM, U244, Grenoble, France
关键词
calcium binding proteins; cancer; immunohistochemistry; S100; proteins; S100A6; S100A8; S100A9; S100A11;
D O I
10.1111/j.1365-2559.2005.02097.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: To survey the expression of members of the S100 family of calcium-binding proteins in normal human tissues and common cancers using tissue microarrays. S100A6, S100A8, S100A9 and S100A11 have all been suggested to have potential roles in carcinogenesis and tumour progression but their expression has not been described in a wide range of human tissues and tumours. Methods and results: A custom-made tissue array, containing 291 tissue cores representing 28 tissue types and 21 tumour types, was used to produce sections that were immunostained for S100A2, S100A6, S100A8, S100A9, S100A11, calbindin 1, calbindin 2, S100B and parvalbumin. S100A6, S100A8 and S100A9 were expressed in 32%, 12% and 28% of breast cancers, respectively. There was a translocation of S100A11 expression from exclusively nuclear in normal tissues to cytoplasmic and nuclear in all common cancers. Conclusions: S100A6, S100A8, S100A9 and S100A11 are all expressed in common cancers, especially breast cancer. In addition, S100A11 undergoes a nucleocytoplasmic translocation which may have a direct influence on the proliferation of the cancer cells.
引用
收藏
页码:256 / 269
页数:14
相关论文
共 50 条
  • [1] Tissue mRNA for S100A4, S100A6, S100A8, S100A9, S100A11 and S100P Proteins in Colorectal Neoplasia: A Pilot Study
    Peterova, Eva
    Bures, Jan
    Moravkova, Paula
    Kohoutova, Darina
    MOLECULES, 2021, 26 (02):
  • [2] Serum S100A6, S100A8, S100A9 and S100A11 proteins in colorectal neoplasia: results of a single centre prospective study
    Moravkova, Paula
    Kohoutova, Darina
    Vavrova, Jaroslava
    Bures, Jan
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2020, 80 (03): : 173 - 178
  • [3] SERUM S100A6, S100A8, S100A9 AND S100A11 IN COLORECTAL NEOPLASIA: RESULTS OF A SINGLE CENTRE PROSPECTIVE STUDY
    Moravkova, Paula
    Kohoutova, Darina
    Vavrova, Jaroslava
    Bures, Jan
    GASTROENTEROLOGY, 2018, 154 (06) : S1060 - S1061
  • [4] S100A8 and S100A9 in Cancer
    Chen, Yu
    Ouyang, Yuzhen
    Li, Zhixin
    Wang, Xiufang
    Ma, Jian
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (03):
  • [5] S100A8, S100A9 and S100A12 proteins in rheumatoid arthritis
    Baillet, A.
    REVUE DE MEDECINE INTERNE, 2010, 31 (06): : 458 - 461
  • [6] Tissue microarray immunohistochemistry for S100A2, S100A4, S100A6, S100A8, S100A9, S100B and annexin I with unsupervised cluster analysis produces a useful classification of oesophageal cancers
    Clarke, LC
    Harrison, RF
    Rehman, I
    Leiblich, A
    Bury, JP
    Ackroyd, R
    Stoddard, CJ
    Wyman, A
    Hamdy, FC
    Cross, S
    JOURNAL OF PATHOLOGY, 2005, 207 : 50 - 50
  • [7] Chemotactic activity of S100A8 and S100A9
    Roth, J
    Vogl, T
    Sunderkötter, C
    Sorg, C
    JOURNAL OF IMMUNOLOGY, 2003, 171 (11): : 5651 - 5651
  • [8] S100A8 and S100A9 in experimental osteoarthritis
    Zreiqat, Hala
    Belluoccio, Daniele
    Smith, Margaret M.
    Wilson, Richard
    Rowley, Lynn A.
    Jones, Katie
    Ramaswamy, Yogambha
    Vogl, Thomas
    Roth, Johannes
    Bateman, John F.
    Little, Christopher B.
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (01)
  • [9] S100A8 and S100A9 in inflammation and cancer
    Gebhardt, Christoffer
    Nemeth, Julia
    Angel, Peter
    Hess, Jochen
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (11) : 1622 - 1631
  • [10] S100A8 and S100A9 in inflammatory diseases
    Roth, J
    Goebeler, M
    Sorg, C
    LANCET, 2001, 357 (9261): : 1041 - 1041